Showing results (481-490 of 499) with videos related to

Sort By:
Pageof 50
Journal of Clinical Medicine|May 4, 2026
Evidence Map of Pharmacologic and Non-Pharmacologic Perioperative Strategies for Managing Acute Postoperative Pain After Laparoscopic Surgery, 2012-2025: The M-PALS CollaborativeRomil R Parikh, Gabriella L Lott, Miranda Considine, et al.
Nature Communications|April 24, 2021
Genomic profile of advanced breast cancer in circulating tumour DNABelinda Kingston, Rosalind J Cutts, Hannah Bye, et al.
Breast (Edinburgh, Scotland)|October 3, 2018
The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective reviewE Copson, A M Shaaban, T Maishman, et al.
JACC. Asia|November 7, 2022
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific RegionHayato Tada, Khung Keong Yeo, Jian-Jun Li, et al.
Molecular Cancer Therapeutics|November 5, 2016
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of LapatinibMichael F Press, Catherine E Ellis, Robert C Gagnon, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 31, 2020
Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effectsJian-Jun Li, Hui-Hui Liu, Na-Qiong Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 6, 2014
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatmentSjoukje F Oosting, Adrienne H Brouwers, Suzanne C van Es, et al.
The Lancet. Oncology|September 13, 2020
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C Turner, Belinda Kingston, Lucy S Kilburn, et al.
Circulation|September 25, 2023
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE TrialPeter A Henriksen, Peter Hall, Iain R MacPherson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
Pageof 50